Case report of lung cancer and pulmonary lymphangitic carcinomatosis in a 12-year-old boy

Jing-Wen YU, Han HUANG, Li-Li ZHONG, Min CHEN, Zhuo-Jie YANG

Chinese Journal of Contemporary Pediatrics ›› 2025, Vol. 27 ›› Issue (5) : 618-622.

PDF(1228 KB)
PDF(1228 KB)
Chinese Journal of Contemporary Pediatrics ›› 2025, Vol. 27 ›› Issue (5) : 618-622. DOI: 10.7499/j.issn.1008-8830.2412107
CASE REPORT

Case report of lung cancer and pulmonary lymphangitic carcinomatosis in a 12-year-old boy

Author information +
History +

Abstract

A 12-year-old boy was admitted with symptoms of cough and fever lasting over a month, accompanied by weight loss 2 kg. Prior anti-infective treatments proved ineffective in alleviating the symptoms. Chest imaging revealed diffuse interstitial pulmonary edema in the right lung with obstructed lymphatic drainage. Combined with histopathological examinations, the diagnosis was confirmed as lung cancer with pulmonary lymphangitic carcinomatosis. The patient underwent chemotherapy with docetaxel and carboplatin, yet the disease progressively worsened, resulting in death three months after diagnosis. This case highlights lung cancer should not be overlooked in patients with persistent respiratory symptoms of unknown etiology. Early imaging examinations, along with necessary pathological evaluations, are crucial for timely detection and diagnosis. The presence of pulmonary lymphangitic carcinomatosis often indicates an advanced-stage of cancer, associated with a poor prognosis.

Key words

Pulmonary lymphangitic carcinomatosis / Lung cancer / Child

Cite this article

Download Citations
Jing-Wen YU , Han HUANG , Li-Li ZHONG , et al . Case report of lung cancer and pulmonary lymphangitic carcinomatosis in a 12-year-old boy[J]. Chinese Journal of Contemporary Pediatrics. 2025, 27(5): 618-622 https://doi.org/10.7499/j.issn.1008-8830.2412107

References

1
Pallis AG, Agelaki S, Agelidou A, et al. A randomized phase III study of the docetaxel/carboplatin combination versus docetaxel single-agent as second line treatment for patients with advanced/metastatic non-small cell lung cancer[J]. BMC Cancer, 2010, 10: 633. PMCID: PMC2994826. DOI: 10.1186/1471-2407-10-633 .
2
Shao W, Liu J, Li B, et al. Primary lung cancer in children and adolescents: analysis of a surveillance, epidemiology, and end results database[J]. Front Oncol, 2023, 13: 1053248. PMCID: PMC10113610. DOI: 10.3389/fonc.2023.1053248 .
3
Dawani A, Bhalla AS, Jana M, et al. Primary pulmonary tumors in pediatric population: imaging markers for predicting histology[J]. J Indian Assoc Pediatr Surg, 2020, 25(6): 363-367. PMCID: PMC7815042. DOI: 10.4103/jiaps.JIAPS_156_19 .
4
Özcan HN, Atak F, Oğuz B, et al. Imaging findings of primary lung tumors in children[J]. Diagn Interv Radiol, 2024, 30(6): 419-426. PMCID: PMC11589528. DOI: 10.4274/dir.2024.242714 .
5
AK AK, Mantri SN. Lymphangitic Carcinomatosis. 2023 Jul 4. In: StatPearls [Internet]. PMID:
6
Klimek M. Pulmonary lymphangitis carcinomatosis: systematic review and meta-analysis of case reports, 1970-2018[J]. Postgrad Med, 2019, 131(5): 309-318. DOI: 10.1080/00325481.2019.1595982 .
7
Olesen SR, Kronborg-White S, Madsen LB, et al. Interstitial lung disease was suspected, but biopsy revealed pulmonary lymphangitis carcinomatosa[J]. Eur Clin Respir J, 2024, 11(1): 2365510. PMCID: PMC11188942. DOI: 10.1080/20018525.2024.2365510 .
8
Alduais Y, Zhang H, Fan F, et al. Non-small cell lung cancer (NSCLC): a review of risk factors, diagnosis, and treatment[J]. Medicine (Baltimore), 2023, 102(8): e32899. PMCID: PMC11309591. DOI: 10.1097/MD.0000000000032899 .
9
Youlden DR, Foresto SA, Aitken JF. Primary malignant lung tumors in children: a report from the Australian Childhood Cancer Registry, 1983-2015[J]. Pediatr Pulmonol, 2020, 55(3): 719-722. DOI: 10.1002/ppul.24636 .
10
Chen L, Feng S, Chen X, et al. Low-dose apatinib in combination with chemotherapy for hormone receptor-positive, HER2-negative breast cancer with pulmonary lymphangitic carcinomatosis: a case report[J]. Medicine (Baltimore), 2024, 103(45): e40345. PMCID: PMC11556957. DOI: 10.1097/MD.0000000000040345 .
11
Toshima H, Ikusue T, Hisamatsu A, et al. Two cases of lymphangitic carcinomatosis as the primary symptom of colorectal carcinoma that achieved complete remission using combination anti-EGFR antibody therapy[J]. Onco Targets Ther, 2019, 12: 2089-2093. PMCID: PMC6430998. DOI: 10.2147/OTT.S194224 .

喻静雯、杨焯杰负责数据收集、整理、分析及论文撰写;黄寒、钟礼立和陈敏负责分析及修改;黄寒负责构思、设计及修改。

PDF(1228 KB)

Accesses

Citation

Detail

Sections
Recommended

/